25 XP   0   0   10

Algorae Pharmaceuticals Limited
Buy, Hold or Sell?

Let's analyse Algorae Pharmaceuticals Limited together

PenkeI guess you are interested in Algorae Pharmaceuticals Limited . Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Algorae Pharmaceuticals Limited . At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Algorae Pharmaceuticals Limited

I send you an email if I find something interesting about Algorae Pharmaceuticals Limited .

Quick analysis of Algorae Pharmaceuticals Limited (30 sec.)










What can you expect buying and holding a share of Algorae Pharmaceuticals Limited ? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.00
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-6.6%

For what price can you sell your share?

Current Price per Share
A$0.01
Expected price per share
A$0.009 - A$0.011
How sure are you?
50%

1. Valuation of Algorae Pharmaceuticals Limited (5 min.)




Live pricePrice per Share (EOD)

A$0.01

Intrinsic Value Per Share

A$-0.02 - A$0.00

Total Value Per Share

A$-0.02 - A$0.00

2. Growth of Algorae Pharmaceuticals Limited (5 min.)




Is Algorae Pharmaceuticals Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$2.4m$2.6m-$176.3k-7.2%

How much money is Algorae Pharmaceuticals Limited making?

Current yearPrevious yearGrowGrow %
Making money-$1.3m-$1.2m-$97.2k-7.1%
Net Profit Margin-5,015.8%-57,398.8%--

How much money comes from the company's main activities?

3. Financial Health of Algorae Pharmaceuticals Limited (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Algorae Pharmaceuticals Limited ? (5 min.)

Welcome investor! Algorae Pharmaceuticals Limited 's management wants to use your money to grow the business. In return you get a share of Algorae Pharmaceuticals Limited .

What can you expect buying and holding a share of Algorae Pharmaceuticals Limited ?

First you should know what it really means to hold a share of Algorae Pharmaceuticals Limited . And how you can make/lose money.

Speculation

The Price per Share of Algorae Pharmaceuticals Limited is A$0.01. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Algorae Pharmaceuticals Limited .
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Algorae Pharmaceuticals Limited , you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Algorae Pharmaceuticals Limited .

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-8.2%0.00-8.2%0.00-7.6%0.00-7.5%0.00-12.1%
Usd Book Value Change Per Share0.00-1.1%0.00-1.1%0.0010.3%0.00-2.6%0.00-3.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-1.1%0.00-1.1%0.0010.3%0.00-2.6%0.00-3.7%
Usd Price Per Share0.01-0.01-0.01-0.01-0.02-
Price to Earnings Ratio-11.82--11.82--6.71--12.52--26.99-
Price-to-Total Gains Ratio-91.38--91.38-4.94--25.29-3.55-
Price to Book Ratio6.62-6.62-3.25-7.83-11.28-
Price-to-Total Gains Ratio-91.38--91.38-4.94--25.29-3.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.006467
Number of shares154631
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (154631 shares)-16.42-40.61
Gains per Year (154631 shares)-65.66-162.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-66-760-162-172
20-131-1420-325-334
30-197-2080-487-496
40-263-2740-650-658
50-328-3400-812-820
60-394-4060-975-982
70-460-4720-1137-1144
80-525-5380-1299-1306
90-591-6040-1462-1468
100-657-6700-1624-1630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%1.017.02.05.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.07.00.030.0%8.012.00.040.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.020.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%3.07.00.030.0%8.012.00.040.0%

Fundamentals of Algorae Pharmaceuticals Limited

About Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limited, a biotechnology company, focuses on developing solutions for Parkinson's disease in Australia. It is developing NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient treatment for dementia, including Alzheimer's disease. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. The company was founded in 1987 and is based in Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-03-28 01:31:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Algorae Pharmaceuticals Limited .

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Algorae Pharmaceuticals Limited earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Algorae Pharmaceuticals Limited to the Biotechnology industry mean.
  • A Net Profit Margin of -5,015.8% means that $-50.16 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Algorae Pharmaceuticals Limited :

  • The MRQ is -5,015.8%. The company is making a huge loss. -2
  • The TTM is -5,015.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-5,015.8%TTM-5,015.8%0.0%
TTM-5,015.8%YOY-57,398.8%+52,383.0%
TTM-5,015.8%5Y-25,219.1%+20,203.3%
5Y-25,219.1%10Y-13,377.1%-11,842.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,015.8%-206.1%-4,809.7%
TTM-5,015.8%-214.1%-4,801.7%
YOY-57,398.8%-279.3%-57,119.5%
5Y-25,219.1%-457.4%-24,761.7%
10Y-13,377.1%-634.2%-12,742.9%
1.1.2. Return on Assets

Shows how efficient Algorae Pharmaceuticals Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Algorae Pharmaceuticals Limited to the Biotechnology industry mean.
  • -50.0% Return on Assets means that Algorae Pharmaceuticals Limited generated $-0.50 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Algorae Pharmaceuticals Limited :

  • The MRQ is -50.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -50.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-50.0%TTM-50.0%0.0%
TTM-50.0%YOY-45.8%-4.2%
TTM-50.0%5Y-53.7%+3.7%
5Y-53.7%10Y-56.9%+3.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-50.0%-14.8%-35.2%
TTM-50.0%-14.1%-35.9%
YOY-45.8%-12.8%-33.0%
5Y-53.7%-16.0%-37.7%
10Y-56.9%-17.6%-39.3%
1.1.3. Return on Equity

Shows how efficient Algorae Pharmaceuticals Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Algorae Pharmaceuticals Limited to the Biotechnology industry mean.
  • -56.0% Return on Equity means Algorae Pharmaceuticals Limited generated $-0.56 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Algorae Pharmaceuticals Limited :

  • The MRQ is -56.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -56.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-56.0%TTM-56.0%0.0%
TTM-56.0%YOY-48.5%-7.5%
TTM-56.0%5Y-64.2%+8.2%
5Y-64.2%10Y-65.3%+1.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-56.0%-18.4%-37.6%
TTM-56.0%-16.9%-39.1%
YOY-48.5%-17.9%-30.6%
5Y-64.2%-21.9%-42.3%
10Y-65.3%-23.1%-42.2%

1.2. Operating Efficiency of Algorae Pharmaceuticals Limited .

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Algorae Pharmaceuticals Limited is operating .

  • Measures how much profit Algorae Pharmaceuticals Limited makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Algorae Pharmaceuticals Limited to the Biotechnology industry mean.
  • An Operating Margin of -5,069.1% means the company generated $-50.69  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Algorae Pharmaceuticals Limited :

  • The MRQ is -5,069.1%. The company is operating very inefficient. -2
  • The TTM is -5,069.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-5,069.1%TTM-5,069.1%0.0%
TTM-5,069.1%YOY-69,339.9%+64,270.7%
TTM-5,069.1%5Y-43,540.8%+38,471.6%
5Y-43,540.8%10Y-22,644.1%-20,896.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,069.1%-287.7%-4,781.4%
TTM-5,069.1%-242.2%-4,826.9%
YOY-69,339.9%-288.4%-69,051.5%
5Y-43,540.8%-480.7%-43,060.1%
10Y-22,644.1%-637.5%-22,006.6%
1.2.2. Operating Ratio

Measures how efficient Algorae Pharmaceuticals Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 50.69 means that the operating costs are $50.69 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Algorae Pharmaceuticals Limited :

  • The MRQ is 50.691. The company is inefficient in keeping operating costs low. -1
  • The TTM is 50.691. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ50.691TTM50.6910.000
TTM50.691YOY697.008-646.316
TTM50.6915Y436.529-385.838
5Y436.52910Y230.759+205.771
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ50.6913.230+47.461
TTM50.6913.283+47.408
YOY697.0083.832+693.176
5Y436.5295.741+430.788
10Y230.7597.992+222.767

1.3. Liquidity of Algorae Pharmaceuticals Limited .

1.3. Liquidity
1.3.1. Current Ratio

Measures if Algorae Pharmaceuticals Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.35 means the company has $9.35 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Algorae Pharmaceuticals Limited :

  • The MRQ is 9.352. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.352. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.352TTM9.3520.000
TTM9.352YOY17.841-8.489
TTM9.3525Y9.306+0.045
5Y9.30610Y9.766-0.460
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3523.986+5.366
TTM9.3524.269+5.083
YOY17.8415.498+12.343
5Y9.3065.971+3.335
10Y9.7666.408+3.358
1.3.2. Quick Ratio

Measures if Algorae Pharmaceuticals Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Algorae Pharmaceuticals Limited to the Biotechnology industry mean.
  • A Quick Ratio of 9.35 means the company can pay off $9.35 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Algorae Pharmaceuticals Limited :

  • The MRQ is 9.352. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.352. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.352TTM9.3520.000
TTM9.352YOY17.841-8.489
TTM9.3525Y9.358-0.006
5Y9.35810Y9.713-0.355
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3523.757+5.595
TTM9.3524.124+5.228
YOY17.8415.504+12.337
5Y9.3585.943+3.415
10Y9.7136.225+3.488

1.4. Solvency of Algorae Pharmaceuticals Limited .

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Algorae Pharmaceuticals Limited  assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Algorae Pharmaceuticals Limited to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.11 means that Algorae Pharmaceuticals Limited assets are financed with 10.7% credit (debt) and the remaining percentage (100% - 10.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Algorae Pharmaceuticals Limited :

  • The MRQ is 0.107. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.107. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.107TTM0.1070.000
TTM0.107YOY0.056+0.051
TTM0.1075Y0.151-0.045
5Y0.15110Y0.124+0.027
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1070.328-0.221
TTM0.1070.326-0.219
YOY0.0560.266-0.210
5Y0.1510.370-0.219
10Y0.1240.396-0.272
1.4.2. Debt to Equity Ratio

Measures if Algorae Pharmaceuticals Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Algorae Pharmaceuticals Limited to the Biotechnology industry mean.
  • A Debt to Equity ratio of 12.0% means that company has $0.12 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Algorae Pharmaceuticals Limited :

  • The MRQ is 0.120. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.120. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.120TTM0.1200.000
TTM0.120YOY0.059+0.060
TTM0.1205Y0.188-0.069
5Y0.18810Y0.149+0.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1200.371-0.251
TTM0.1200.384-0.264
YOY0.0590.328-0.269
5Y0.1880.423-0.235
10Y0.1490.450-0.301

2. Market Valuation of Algorae Pharmaceuticals Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Algorae Pharmaceuticals Limited generates.

  • Above 15 is considered overpriced but always compare Algorae Pharmaceuticals Limited to the Biotechnology industry mean.
  • A PE ratio of -11.82 means the investor is paying $-11.82 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Algorae Pharmaceuticals Limited :

  • The EOD is -7.882. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.824. Based on the earnings, the company is expensive. -2
  • The TTM is -11.824. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.882MRQ-11.824+3.941
MRQ-11.824TTM-11.8240.000
TTM-11.824YOY-6.705-5.118
TTM-11.8245Y-12.524+0.701
5Y-12.52410Y-26.989+14.465
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.882-2.543-5.339
MRQ-11.824-2.591-9.233
TTM-11.824-2.669-9.155
YOY-6.705-4.234-2.471
5Y-12.524-6.310-6.214
10Y-26.989-6.212-20.777
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Algorae Pharmaceuticals Limited :

  • The EOD is -8.364. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.546. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.546. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.364MRQ-12.546+4.182
MRQ-12.546TTM-12.5460.000
TTM-12.546YOY-6.695-5.851
TTM-12.5465Y-11.401-1.145
5Y-11.40110Y-111.638+100.236
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.364-3.382-4.982
MRQ-12.546-3.363-9.183
TTM-12.546-3.653-8.893
YOY-6.695-5.822-0.873
5Y-11.401-8.477-2.924
10Y-111.638-8.811-102.827
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Algorae Pharmaceuticals Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.62 means the investor is paying $6.62 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Algorae Pharmaceuticals Limited :

  • The EOD is 4.416. Based on the equity, the company is fair priced.
  • The MRQ is 6.624. Based on the equity, the company is overpriced. -1
  • The TTM is 6.624. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.416MRQ6.624-2.208
MRQ6.624TTM6.6240.000
TTM6.624YOY3.253+3.371
TTM6.6245Y7.829-1.205
5Y7.82910Y11.278-3.449
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.4162.030+2.386
MRQ6.6242.133+4.491
TTM6.6242.124+4.500
YOY3.2532.943+0.310
5Y7.8293.477+4.352
10Y11.2783.682+7.596
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Algorae Pharmaceuticals Limited .

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Algorae Pharmaceuticals Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.0000%0.002-110%0.000+147%-0.001+248%
Book Value Per Share--0.0020.0020%0.002-7%0.002+16%0.003-25%
Current Ratio--9.3529.3520%17.841-48%9.306+0%9.766-4%
Debt To Asset Ratio--0.1070.1070%0.056+91%0.151-29%0.124-14%
Debt To Equity Ratio--0.1200.1200%0.059+102%0.188-36%0.149-20%
Dividend Per Share----0%-0%-0%-0%
Eps---0.001-0.0010%-0.001-7%-0.001-8%-0.002+47%
Free Cash Flow Per Share---0.001-0.0010%-0.001-1%-0.001+6%-0.001+25%
Free Cash Flow To Equity Per Share--0.0000.0000%0.002-105%0.000+506%0.000-48%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.001--------
Intrinsic Value_10Y_min---0.018--------
Intrinsic Value_1Y_max---0.001--------
Intrinsic Value_1Y_min---0.002--------
Intrinsic Value_3Y_max---0.002--------
Intrinsic Value_3Y_min---0.005--------
Intrinsic Value_5Y_max---0.002--------
Intrinsic Value_5Y_min---0.009--------
Market Cap16613500.160-50%24920250.24024920250.2400%13124665.126+90%22660814.218+10%59924895.077-58%
Net Profit Margin---50.158-50.1580%-573.988+1044%-252.191+403%-133.771+167%
Operating Margin---50.691-50.6910%-693.399+1268%-435.408+759%-226.441+347%
Operating Ratio--50.69150.6910%697.008-93%436.529-88%230.759-78%
Pb Ratio4.416-50%6.6246.6240%3.253+104%7.829-15%11.278-41%
Pe Ratio-7.882+33%-11.824-11.8240%-6.705-43%-12.524+6%-26.989+128%
Price Per Share0.010-50%0.0150.0150%0.008+90%0.014+10%0.036-58%
Price To Free Cash Flow Ratio-8.364+33%-12.546-12.5460%-6.695-47%-11.401-9%-111.638+790%
Price To Total Gains Ratio-60.918+33%-91.376-91.3760%4.938-1950%-25.285-72%3.546-2677%
Quick Ratio--9.3529.3520%17.841-48%9.3580%9.713-4%
Return On Assets---0.500-0.5000%-0.458-8%-0.537+7%-0.569+14%
Return On Equity---0.560-0.5600%-0.485-13%-0.642+15%-0.653+17%
Total Gains Per Share--0.0000.0000%0.002-110%0.000+147%-0.001+248%
Usd Book Value--2432952.0102432952.0100%2609320.681-7%2094129.454+16%3238651.030-25%
Usd Book Value Change Per Share--0.0000.0000%0.001-110%0.000+147%0.000+248%
Usd Book Value Per Share--0.0010.0010%0.002-7%0.001+16%0.002-25%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.0010%-0.001-7%-0.001-8%-0.001+47%
Usd Free Cash Flow---1284534.390-1284534.3900%-1267764.812-1%-1360057.438+6%-1606868.941+25%
Usd Free Cash Flow Per Share---0.001-0.0010%-0.001-1%-0.001+6%-0.001+25%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.001-105%0.000+506%0.000-48%
Usd Market Cap10743950.553-50%16115925.83016115925.8300%8487720.937+90%14654748.555+10%38753429.646-58%
Usd Price Per Share0.006-50%0.0100.0100%0.005+90%0.009+10%0.023-58%
Usd Profit---1363022.429-1363022.4290%-1265785.910-7%-1251413.779-8%-2008365.070+47%
Usd Revenue--27174.33427174.3340%2205.247+1132%42235.589-36%561943.821-95%
Usd Total Gains Per Share--0.0000.0000%0.001-110%0.000+147%0.000+248%
 EOD+3 -5MRQTTM+0 -0YOY+9 -245Y+25 -810Y+19 -14

4.2. Fundamental Score

Let's check the fundamental score of Algorae Pharmaceuticals Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.882
Price to Book Ratio (EOD)Between0-14.416
Net Profit Margin (MRQ)Greater than0-50.158
Operating Margin (MRQ)Greater than0-50.691
Quick Ratio (MRQ)Greater than19.352
Current Ratio (MRQ)Greater than19.352
Debt to Asset Ratio (MRQ)Less than10.107
Debt to Equity Ratio (MRQ)Less than10.120
Return on Equity (MRQ)Greater than0.15-0.560
Return on Assets (MRQ)Greater than0.05-0.500
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Algorae Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.391
Ma 20Greater thanMa 500.010
Ma 50Greater thanMa 1000.010
Ma 100Greater thanMa 2000.011
OpenGreater thanClose0.010
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets4,212
Total Liabilities450
Total Stockholder Equity3,762
 As reported
Total Liabilities 450
Total Stockholder Equity+ 3,762
Total Assets = 4,212

Assets

Total Assets4,212
Total Current Assets4,207
Long-term Assets5
Total Current Assets
Cash And Cash Equivalents 4,111
Net Receivables 96
Total Current Assets  (as reported)4,207
Total Current Assets  (calculated)4,207
+/-0
Long-term Assets
Property Plant Equipment 5
Long-term Assets  (as reported)5
Long-term Assets  (calculated)5
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities450
Long-term Liabilities0
Total Stockholder Equity3,762
Total Current Liabilities
Accounts payable 184
Other Current Liabilities 266
Total Current Liabilities  (as reported)450
Total Current Liabilities  (calculated)450
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock80,239
Retained Earnings -80,728
Other Stockholders Equity 4,251
Total Stockholder Equity (as reported)3,762
Total Stockholder Equity (calculated)3,762
+/-0
Other
Capital Stock80,239
Cash and Short Term Investments 4,111
Common Stock Shares Outstanding 1,635,146
Liabilities and Stockholders Equity 4,212
Net Debt -4,111
Net Invested Capital 3,762
Net Tangible Assets 3,762
Net Working Capital 3,757
Property Plant and Equipment Gross 11



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-30
> Total Assets 
1,309
3,945
4,258
3,817
12,241
6,500
6,943
7,472
15,523
14,218
9,665
5,465
6,312
8,694
7,609
5,760
3,391
1,642
4,274
4,212
4,2124,2741,6423,3915,7607,6098,6946,3125,4659,66514,21815,5237,4726,9436,50012,2413,8174,2583,9451,309
   > Total Current Assets 
631
2,718
3,003
2,568
10,984
3,280
3,845
4,711
3,385
5,463
5,065
5,355
5,770
8,177
7,167
5,397
3,073
1,626
4,269
4,207
4,2074,2691,6263,0735,3977,1678,1775,7705,3555,0655,4633,3854,7113,8453,28010,9842,5683,0032,718631
       Cash And Cash Equivalents 
486
2,648
2,956
2,450
10,767
2,868
3,122
4,505
3,170
4,504
4,554
5,144
5,302
7,530
6,862
4,908
2,965
1,569
4,239
4,111
4,1114,2391,5692,9654,9086,8627,5305,3025,1444,5544,5043,1704,5053,1222,86810,7672,4502,9562,648486
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43
43
0
0
0043430000000000000000
       Net Receivables 
115
43
1
32
173
277
711
167
184
840
485
89
334
531
259
466
98
14
30
96
963014984662595313348948584018416771127717332143115
       Inventory 
30
16
32
43
39
0
0
0
0
89
0
0
72
71
1
1
0
0
0
0
0000117172008900003943321630
       Other Current Assets 
0
10
12
43
5
135
12
39
31
30
25
122
63
45
45
21
10
0
0
0
0001021454563122253031391213554312100
   > Long-term Assets 
678
1,227
1,256
1,250
1,257
3,220
3,099
2,761
12,138
8,755
4,600
110
542
518
442
363
318
16
5
5
55163183634425185421104,6008,75512,1382,7613,0993,2201,2571,2501,2561,227678
       Property Plant Equipment 
678
882
949
909
917
2,918
2,794
2,471
38
55
19
42
401
377
304
179
276
16
5
5
5516276179304377401421955382,4712,7942,918917909949882678
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
4,581
67
0
0
42
85
42
0
0
0
00042854200674,5810000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
141
140
95
99
0
0
0
0
00009995140141000000000000
> Total Liabilities 
2,635
809
2,515
2,416
714
973
704
711
1,170
966
1,233
338
636
1,176
473
1,621
513
265
239
450
4502392655131,6214731,1766363381,2339661,1707117049737142,4162,5158092,635
   > Total Current Liabilities 
2,413
806
575
2,416
678
973
704
711
1,170
966
1,233
338
636
1,176
473
1,621
311
265
239
450
4502392653111,6214731,1766363381,2339661,1707117049736782,4165758062,413
       Short-term Debt 
833
24
0
1,878
29
37
7
0
0
0
0
0
0
0
0
53
53
0
0
0
000535300000000737291,878024833
       Accounts payable 
644
634
438
365
435
612
287
363
362
511
264
80
122
886
305
1,459
104
43
47
184
18447431041,45930588612280264511362363287612435365438634644
       Other Current Liabilities 
935
148
136
173
214
324
410
348
292
455
195
141
514
300
169
162
154
222
192
266
266192222154162169300514141195455292348410324214173136148935
   > Long-term Liabilities 
222
3
1,940
0
36
0
0
0
0
0
0
0
0
0
0
202
202
43
47
0
0474320220200000000003601,9403222
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
202
0
0
0
0002020000000000000000
       Long term Debt 
222
3
1,887
0
36
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000003601,8873222
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255
0
0
0
0002550000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000
> Total Stockholder Equity
-1,325
3,136
1,744
1,401
11,527
5,527
6,240
6,760
14,353
13,252
8,432
5,127
5,677
7,518
7,135
4,138
2,878
1,377
4,035
3,762
3,7624,0351,3772,8784,1387,1357,5185,6775,1278,43213,25214,3536,7606,2405,52711,5271,4011,7443,136-1,325
   Common Stock
8,982
19,537
24,685
29,872
46,049
46,049
52,431
59,353
60,686
60,686
60,686
64,752
68,406
74,340
74,371
74,371
74,371
74,371
78,950
80,239
80,23978,95074,37174,37174,37174,37174,34068,40664,75260,68660,68660,68659,35352,43146,04946,04929,87224,68519,5378,982
   Retained Earnings -80,728-78,744-76,787-75,326-74,358-71,176-70,802-66,711-63,618-56,575-50,099-47,664-53,657-47,665-41,991-35,867-29,541-23,543-16,401-10,308
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
308
3,993
3,982
3,980
3,940
4,125
3,833
3,793
3,829
4,251
4,2513,8293,7933,8334,1253,9403,9803,9823,9933080000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.